OTSUKA PHARMACEUTICAL EUROPE LTD.

03456326
Active Windsor

Activities of head offices

152 employees website.com
Life sciences and medical technology Activities of head officesOther research and experimental development on natural sciences and engineering
O

OTSUKA PHARMACEUTICAL EUROPE LTD.

03456326

Activities of head offices

Founded 28 Oct 1997 Active Windsor, England 152 employees website.com
Life sciences and medical technology Activities of head officesOther research and experimental development on natural sciences and engineering
Accounts Submitted 15 Aug 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 11 Nov 2025 Next due 11 Nov 2026 4 months remaining
Net assets £167M £20M 2024 year on year
Total assets £285M £4M 2024 year on year
Total Liabilities £118M £16M 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

2 Windsor Dials Arthur Road Windsor SL4 1RS England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for OTSUKA PHARMACEUTICAL EUROPE LTD. (03456326), an active life sciences and medical technology company based in Windsor, England. Incorporated 28 Oct 1997. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2016–2024)

Cash in Bank

£79.48M

Increased by £15.74M (+25%)

Net Assets

£166.57M

Decreased by £20.32M (-11%)

Total Liabilities

£118.43M

Increased by £15.83M (+15%)

Turnover

£308.94M

Decreased by £17.24M (-5%)

Employees

152

Increased by 11 (+8%)

Debt Ratio

42%

Increased by 7 (+20%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 2

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Mitre Secretaries LimitedCorporate-secretaryBritishUnknown28 Oct 1997Active

Shareholders

Shareholders (1)

Otsuka Pharmaceutical Co., Ltd.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Otsuka Holdings Co., Ltd.

Unknown

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

OTSUKA PHARMACEUTICAL EUROPE LTD. Current Company

Charges

Charges

2 outstanding

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
2, Windsor Dials, Arthur Road, Windsor (SL4 1RS) WINDSOR AND MAIDENHEAD
Leasehold-2 Mar 2023
Gallions, Wexham Springs, Framewood Road, Wexham, Slough (SL3 6PJ) BUCKINGHAMSHIRE
Leasehold-11 Jun 2013
2, Windsor Dials, Arthur Road, Windsor (SL4 1RS)
Leasehold
Added 2 Mar 2023
District WINDSOR AND MAIDENHEAD
Gallions, Wexham Springs, Framewood Road, Wexham, Slough (SL3 6PJ)
Leasehold
Added 11 Jun 2013
District BUCKINGHAMSHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
11 Nov 2025Confirmation StatementConfirmation statement made on 28 Oct 2025 with no updates
15 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
14 Feb 2025OfficersAppointment of Steven Harold Rosen as director on 4 Feb 2025
14 Feb 2025OfficersTermination of Tsuyoshi Nakamura as director on 31 Jan 2025
14 Feb 2025OfficersAppointment of Haruhiko Sugino as director on 4 Feb 2025
11 Nov 2025 Confirmation Statement

Confirmation statement made on 28 Oct 2025 with no updates

15 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

14 Feb 2025 Officers

Appointment of Steven Harold Rosen as director on 4 Feb 2025

14 Feb 2025 Officers

Termination of Tsuyoshi Nakamura as director on 31 Jan 2025

14 Feb 2025 Officers

Appointment of Haruhiko Sugino as director on 4 Feb 2025

Recent Activity

Latest Activity

Confirmation statement made on 28 Oct 2025 with no updates

7 months ago on 11 Nov 2025

Annual accounts made up to 31 Dec 2024

10 months ago on 15 Aug 2025

Appointment of Steven Harold Rosen as director on 4 Feb 2025

1 years ago on 14 Feb 2025

Termination of Tsuyoshi Nakamura as director on 31 Jan 2025

1 years ago on 14 Feb 2025

Appointment of Haruhiko Sugino as director on 4 Feb 2025

1 years ago on 14 Feb 2025